Chemomab Therapeutics Ltd. American Depositary Share

Last updated September 27, 2026

Organization details

Legal name
Chemomab Therapeutics Ltd. American Depositary Share
Former names
Anchiano Therapeutics Ltd. BioCancell Ltd.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Israel
Headquarters city
TEL Aviv
Headquarters country
Israel
Fiscal year end
December
Ticker symbol
CMMB
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001534248
EIN
81-3676773

Board of directors

Chief executives

George Adi Mor · Chief Executive Officer
Since March 2026

Board connections

4 of this board's directors also sit on 6 other boards. 5 are in the same sector.

Network of Chemomab Therapeutics Ltd. American Depositary Share's board connections Filana Therapeutics Inc. Filana Therapeutics In... Gain Therapeutics Inc. Gain Therapeutics Inc. Collegium Pharmaceutical Inc. Collegium Pharmaceutic... Protalix BioTherapeutics Inc. (DE) Protalix BioTherapeuti... Sarepta Therapeutics Inc. Sarepta Therapeutics I... Tessera Defense and Homeland Security Inc. Tessera Defense and Ho... Alan Charles Moses Alan Charles Moses Claude Nicaise Claude Nicaise Gwen A. Melincoff Gwen A. Melincoff Jill M. Quigley Jill M. Quigley Chemomab Therapeutics Ltd....
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$20,246
2 purchases by 1 insider
Sold, last 12 months
$6,516
2 sales by 1 insider
Date Insider Transaction Shares Price Value
Aug 28, 2026 Neil Harris Cohen Director Open-market sale −1,000 $2.80 $2,800
Aug 27, 2026 Neil Harris Cohen Director Open-market sale −1,304 $2.85 $3,716
May 29, 2026 George Adi Mor Director, Officer (Chief Executive Officer) Open-market purchase −4,878 $2.05 $10,000
May 29, 2026 George Adi Mor Director, Officer (Chief Executive Officer) Open-market purchase −4,926 $2.08 $10,246
May 29, 2026 George Adi Mor Director, Officer (Chief Executive Officer) Other −31,712 — —
May 29, 2026 George Adi Mor Director, Officer (Chief Executive Officer) Other −18,750 — —
Jan 3, 2023 OrbiMed Israel BioFund GP Limited Partnership 10% owner Open-market sale −266,376 $3.34 $889,696
Jan 3, 2023 George Adi Mor Director, Officer (Chief Scientific Officer) Open-market sale −7,700 $5.03 $38,731
Jan 3, 2023 OrbiMed Israel BioFund GP Limited Partnership 10% owner Open-market sale −70,524 $4.51 $318,063
Jan 3, 2023 George Adi Mor Director, Officer (Chief Scientific Officer) Open-market sale −6,100 $5.03 $30,683

Organizations in the same sector, closest in location and size first.

Questions about Chemomab Therapeutics Ltd. American Depositary Share

Who is the CEO of Chemomab Therapeutics Ltd. American Depositary Share?

George Adi Mor has been Chemomab Therapeutics Ltd. American Depositary Share's Chief Executive Officer since March 2026.

How many directors are on Chemomab Therapeutics Ltd. American Depositary Share's board?

Chemomab Therapeutics Ltd. American Depositary Share's board has 7 directors: Alan Charles Moses, Claude Nicaise, George Adi Mor, Gwen A. Melincoff, Jill M. Quigley, Neil Harris Cohen and Nissim Darvish.

Are Chemomab Therapeutics Ltd. American Depositary Share insiders buying or selling shares?

Over the last 12 months, Chemomab Therapeutics Ltd. American Depositary Share insiders bought $20,246 of shares in 2 purchases and sold $6,516 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="chemomab-therapeutics-ltd-american-depositary-share"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.